PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Brain waves found in sleep shown to protect against epileptic activity

The neurological condition affects around 50 million people worldwide. Researchers from University College London (UCL) have revealed that slow brain waves that o...
Continue Reading →
News

Prostate cancer focal therapy could improve costs and patient outcomes

Every year, over 44,000 men are diagnosed with prostate cancer in England. A study led by the National Institute for Health and Care Research’s Imperial Biomedica...
Continue Reading →
News

Radiotherapy boost shown to reduce treatment times for breast cancer patients

Every year, around 55,000 women in the UK are diagnosed with the condition. The Royal Marsden NHS Foundation Trust has revealed positive results from a phase 3 tr...
Continue Reading →
News

SMART and CAMP collaborate to develop safer T-cell therapies

The new method successfully performs sterility assessments within 24 hours. Researchers from the Singapore-MIT Alliance for Research and Technology’s (SMART) Crit...
Continue Reading →
News

Almac Discovery and Queen’s University launch state-of-the-art Chemoproteomics facility in Belfast

Almac Discovery and Queen’s University Belfast have today announced a five-year project to develop a new Chemoproteomics Centre of Excellence for drug discovery. ...
Continue Reading →
News

Alladapt’s allergy treatment receives FDA fast track designation

ADP101 is an oral immunotherapy to treat multi-food and single-food allergies. Alladapt Immunotherapeutics has announced that its investigational multi-food oral ...
Continue Reading →
News

Study suggests cognitive decline could be linked to hippocampus shrinkage

The findings could benefit patients living with neurodegenerative conditions. A new study published in the journal Neurology has suggested that as the h...
Continue Reading →
News

AI-powered ‘MesoGraph’ tool could help clinicians diagnose cancer

Around 3,000 new cases of mesothelioma are diagnosed in the US every year. Several researchers, including those from King's College London (KCL), have detailed ho...
Continue Reading →
News

Next-Generation Pharma Manufacturing and Packaging Models at PHARMAP 2024

The topic of new pharma strategies is one of the highlights of the Pharmaceutical Manufacturing and Packaging Congress 2024 (PHARMAP). The Congress gathers the leadi...
Continue Reading →
News

CALLIDITAS’ PARTNER EVEREST MEDICINES ANNOUNCES CHINA NMPA’SAPPROVAL OF NEFECON® FOR THE TREATMENT OF PRIMARY IGA NEPHROPATHY

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") today announced that its partner Everest Medicines (HKEX: 1952.HK) ("Everest") anno...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026